Atlas Trials

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy

Clinical trial NCT04951609 · TERMINATED

Trial details

NCT number
NCT04951609
Sponsor
Janssen Research & Development, LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2021-09-02
Primary completion
2024-04-08
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.